Home > Products > CD44 & CR3
> Recombinant Anti-CD44 x Anti-CR3 Bispecific Antibody (Miniantibody)
Recombinant Anti-CD44 x Anti-CR3 Bispecific Antibody (Miniantibody) (CAT#: MNAB-121)
Recombinant Anti-CD44 x Anti-CR3 Bispecific Antibody (Miniantibody) is a fusion protein of two scFv fragments combined with distinct specificity. One scFv of an anti-CD44 antibody variable domain is linked to another scFv of an anti-CR3 antibody variable domain by a flexible hinge region. This BsAb format has the decreased size and better penetration than conventional IgGs in the clinical diagnostics and potentially therapy. This BsAb can recruit macrophages to tumor cells. It is designed for the research of Glioblastoma; Squamous cancer therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD44 x Anti-CR3 Bispecific Antibody (Miniantibody) (MNAB-121). Click the button below to contact us or submit your feedback about this product.